Vanrafia (Atrasentan)

Vanrafia (atrasentan) is an endothelin receptor antagonist used to reduce protein in the urine (proteinuria) in adults with a kidney disease known as primary immunoglobulin A nephropathy (IgAN) who are at risk of their disease getting worse quickly. It is not known if this therapeutic drug is safe and effective in children.

Note: This medicinal product is approved based on a reduction of proteinuria. Continued approval may require outcomes from an ongoing study to specify whether it slows the decline in kidney function.

Recommended Dosage:
The recommended dosage of Vanrafia is 0.75 mg administered orally (by mouth) once daily with or without food. Swallow oral tablets whole. Do not chew, cut, or crush the tablets.
In case a scheduled dose or doses are missed or skipped, take the prescribed dose at the next scheduled time. It is not advisable to double the dose to make up for a missed or skipped dose.

• Vanrafia 0.75 mg tablets should not be taken by people who are allergic to atrasentan or any drugs that are similar. Signs such as rash, swelling, difficulty breathing, or dizziness might occur. If there are allergic reactions during treatment, then cease use and go to urgent care immediately.
• Liver damage may arise during the use of this therapeutic drug. Signs and symptoms include stomach pain, yellow eyes, dark urine, or unusual tiredness. Perform liver tests before and during this treatment. Stop using this medicine in case liver function worsens or signs and symptoms of liver injury are observed.
• This oral therapeutic drug may be responsible for causing the body to retain fluids. This leads to swelling in the hands, legs, or ankles. This may worsen kidney or heart conditions. Monitor weight and signs of swelling regularly. Let your doctor know in case sudden weight gain or breathing complications arise.
• This medication can decrease sperm count in men, which may impact their ability to father children. These changes could be temporary or lasting. Men who want to father children need to consider the possibilities of fertility preservation with their doctors before undergoing atrasentan treatment.
• Patients with liver problems may have increased concentrations of the drug in their system. This situation can increase the risk of side effects. It may be necessary to lower the dose or increase the frequency of monitoring. Liver function tests should be done regularly during the treatment duration.
• Atrasentan 0.75 mg tablets can be harmful to fetuses. It should not be taken during pregnancy. Women of reproductive age need to use effective birth control during the treatment period as well as for one month after. A pregnancy test is required before starting the medication. If pregnancy does occur, then it is important to notify the physician immediately.
• Currently, it is not known whether atrasentan is excreted through breast milk. Breastfeeding is not recommended while on this medication due to the risks. Therefore, women will have to decide whether to continue breastfeeding or continue taking the medication after consulting with their physician.

What documents are required to import VANRAFIA to India?

VANRAFIA (atrasentan) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is VANRAFIA available in India?

Vanrafia (atrasentan tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Vanrafia in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

VANRAFIA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of VANRAFIA (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Vanrafia 0.75 mg Tablet price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source VANRAFIA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Vanrafia®?

Atrasentan is a Generic Name for the trade name drug Vanrafia®.

What is the Manufacturer's Name of Vanrafia®?

Vanrafia® is manufactured by Novartis Pharmaceuticals Corporation.

Is Vanrafia approved by the FDA?

Yes, Vanrafia® is approved by the FDA. Date of first approval: April 2, 2025.

What is the dosage and form of Vanrafia® supplied?

Vanrafia is supplied for Tablet: 0.75 mg for oral administration.

What are the most common side effects of Vanrafia® 0.75 mg Tablets?

The most common side effects of Vanrafia® tablets are peripheral edema and anemia.

How much does Vanrafia® 0.75 mg Tablet cost in India?

Prices of Vanrafia Tablets may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Vanrafia 0.75 mg tablets cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Vanrafia® 0.75 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Vanrafia® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Vanrafia® Tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Vanrafia® 0.75 mg Tablets online in India?

Yes, one can buy Vanrafia 0.75 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Vanrafia® Tablets through legal channels.

What are the storage conditions of Vanrafia® 0.75 mg Tablets?

Store tablets at 20 to 25°C (68 to 77°F). Excursions are permitted between 15 and 30°C (59 and 86°F). Store and dispense these tablets in its original container.